nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—JUN—stomach cancer	0.594	1	CbGaD
Irbesartan—CYP2C9—Capecitabine—stomach cancer	0.0177	0.236	CbGbCtD
Irbesartan—CYP2C8—Fluorouracil—stomach cancer	0.0151	0.201	CbGbCtD
Irbesartan—CYP1A2—Fluorouracil—stomach cancer	0.0117	0.156	CbGbCtD
Irbesartan—CYP2C9—Fluorouracil—stomach cancer	0.0105	0.14	CbGbCtD
Irbesartan—CYP3A4—Irinotecan—stomach cancer	0.00637	0.0849	CbGbCtD
Irbesartan—CYP2D6—Doxorubicin—stomach cancer	0.00547	0.073	CbGbCtD
Irbesartan—CYP3A4—Docetaxel—stomach cancer	0.00467	0.0623	CbGbCtD
Irbesartan—Tasosartan—AGTR2—stomach cancer	0.00391	0.84	CrCbGaD
Irbesartan—CYP3A4—Doxorubicin—stomach cancer	0.00348	0.0464	CbGbCtD
Irbesartan—JUN—blood vessel—stomach cancer	0.00326	0.0771	CbGeAlD
Irbesartan—AGTR1—blood vessel—stomach cancer	0.00245	0.0581	CbGeAlD
Irbesartan—UGT1A3—digestive system—stomach cancer	0.00213	0.0505	CbGeAlD
Irbesartan—UGT1A3—endocrine gland—stomach cancer	0.00176	0.0417	CbGeAlD
Irbesartan—JUN—hematopoietic system—stomach cancer	0.00174	0.0411	CbGeAlD
Irbesartan—UGT1A3—liver—stomach cancer	0.00159	0.0376	CbGeAlD
Irbesartan—JUN—epithelium—stomach cancer	0.00159	0.0375	CbGeAlD
Irbesartan—JUN—smooth muscle tissue—stomach cancer	0.00153	0.0362	CbGeAlD
Irbesartan—JUN—pancreas—stomach cancer	0.00141	0.0334	CbGeAlD
Irbesartan—AGTR1—hematopoietic system—stomach cancer	0.00131	0.0309	CbGeAlD
Irbesartan—JUN—lymphoid tissue—stomach cancer	0.00122	0.0289	CbGeAlD
Irbesartan—JUN—digestive system—stomach cancer	0.00121	0.0286	CbGeAlD
Irbesartan—AGTR1—epithelium—stomach cancer	0.00119	0.0283	CbGeAlD
Irbesartan—AGTR1—smooth muscle tissue—stomach cancer	0.00115	0.0272	CbGeAlD
Irbesartan—JUN—bone marrow—stomach cancer	0.00111	0.0263	CbGeAlD
Irbesartan—PTGS1—blood vessel—stomach cancer	0.00108	0.0255	CbGeAlD
Irbesartan—JUN—endocrine gland—stomach cancer	0.000997	0.0236	CbGeAlD
Irbesartan—AGTR1—lymphoid tissue—stomach cancer	0.00092	0.0218	CbGeAlD
Irbesartan—JUN—liver—stomach cancer	0.000899	0.0213	CbGeAlD
Irbesartan—EDNRA—lymph node—stomach cancer	0.000755	0.0179	CbGeAlD
Irbesartan—AGTR1—endocrine gland—stomach cancer	0.000751	0.0178	CbGeAlD
Irbesartan—CYP2C8—hematopoietic system—stomach cancer	0.000708	0.0168	CbGeAlD
Irbesartan—JUN—lymph node—stomach cancer	0.000689	0.0163	CbGeAlD
Irbesartan—AGTR1—liver—stomach cancer	0.000677	0.016	CbGeAlD
Irbesartan—CYP1A2—hematopoietic system—stomach cancer	0.000663	0.0157	CbGeAlD
Irbesartan—CYP2C9—hematopoietic system—stomach cancer	0.000629	0.0149	CbGeAlD
Irbesartan—PTGS1—hematopoietic system—stomach cancer	0.000575	0.0136	CbGeAlD
Irbesartan—PTGS1—epithelium—stomach cancer	0.000525	0.0124	CbGeAlD
Irbesartan—AGTR1—lymph node—stomach cancer	0.000519	0.0123	CbGeAlD
Irbesartan—PTGS1—smooth muscle tissue—stomach cancer	0.000506	0.012	CbGeAlD
Irbesartan—CYP3A4—hematopoietic system—stomach cancer	0.00048	0.0114	CbGeAlD
Irbesartan—CYP2D6—hematopoietic system—stomach cancer	0.000472	0.0112	CbGeAlD
Irbesartan—CYP1A2—digestive system—stomach cancer	0.000461	0.0109	CbGeAlD
Irbesartan—CYP2C9—digestive system—stomach cancer	0.000438	0.0104	CbGeAlD
Irbesartan—CYP2C8—endocrine gland—stomach cancer	0.000407	0.00964	CbGeAlD
Irbesartan—PTGS1—digestive system—stomach cancer	0.0004	0.00946	CbGeAlD
Irbesartan—CYP1A2—endocrine gland—stomach cancer	0.000381	0.00902	CbGeAlD
Irbesartan—CYP2C8—liver—stomach cancer	0.000367	0.00869	CbGeAlD
Irbesartan—CYP2C9—endocrine gland—stomach cancer	0.000362	0.00856	CbGeAlD
Irbesartan—CYP1A2—liver—stomach cancer	0.000343	0.00813	CbGeAlD
Irbesartan—CYP3A4—digestive system—stomach cancer	0.000334	0.0079	CbGeAlD
Irbesartan—Losartan—ACE—stomach cancer	0.000332	0.0712	CrCbGaD
Irbesartan—PTGS1—endocrine gland—stomach cancer	0.00033	0.00781	CbGeAlD
Irbesartan—CYP2D6—digestive system—stomach cancer	0.000328	0.00777	CbGeAlD
Irbesartan—CYP2C9—liver—stomach cancer	0.000326	0.00772	CbGeAlD
Irbesartan—Valsartan—ALB—stomach cancer	0.000278	0.0598	CrCbGaD
Irbesartan—CYP3A4—endocrine gland—stomach cancer	0.000276	0.00653	CbGeAlD
Irbesartan—CYP2D6—endocrine gland—stomach cancer	0.000271	0.00642	CbGeAlD
Irbesartan—CYP3A4—liver—stomach cancer	0.000249	0.00589	CbGeAlD
Irbesartan—CYP2D6—liver—stomach cancer	0.000245	0.00579	CbGeAlD
Irbesartan—PTGS1—lymph node—stomach cancer	0.000228	0.0054	CbGeAlD
Irbesartan—Losartan—ALB—stomach cancer	0.000136	0.0292	CrCbGaD
Irbesartan—Headache—Irinotecan—stomach cancer	9.06e-05	0.000633	CcSEcCtD
Irbesartan—Hypotension—Capecitabine—stomach cancer	9.04e-05	0.000632	CcSEcCtD
Irbesartan—Paraesthesia—Docetaxel—stomach cancer	8.98e-05	0.000627	CcSEcCtD
Irbesartan—Bradycardia—Doxorubicin—stomach cancer	8.94e-05	0.000624	CcSEcCtD
Irbesartan—Dyspnoea—Docetaxel—stomach cancer	8.91e-05	0.000622	CcSEcCtD
Irbesartan—Somnolence—Docetaxel—stomach cancer	8.89e-05	0.000621	CcSEcCtD
Irbesartan—Tinnitus—Epirubicin—stomach cancer	8.85e-05	0.000618	CcSEcCtD
Irbesartan—Erythema—Methotrexate—stomach cancer	8.83e-05	0.000617	CcSEcCtD
Irbesartan—Malnutrition—Methotrexate—stomach cancer	8.83e-05	0.000617	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Capecitabine—stomach cancer	8.82e-05	0.000616	CcSEcCtD
Irbesartan—Cardiac disorder—Epirubicin—stomach cancer	8.81e-05	0.000615	CcSEcCtD
Irbesartan—Flushing—Epirubicin—stomach cancer	8.81e-05	0.000615	CcSEcCtD
Irbesartan—Vomiting—Fluorouracil—stomach cancer	8.8e-05	0.000615	CcSEcCtD
Irbesartan—Rhinitis—Doxorubicin—stomach cancer	8.8e-05	0.000615	CcSEcCtD
Irbesartan—Dyspepsia—Docetaxel—stomach cancer	8.8e-05	0.000615	CcSEcCtD
Irbesartan—Hepatitis—Doxorubicin—stomach cancer	8.78e-05	0.000613	CcSEcCtD
Irbesartan—Hypoaesthesia—Doxorubicin—stomach cancer	8.74e-05	0.00061	CcSEcCtD
Irbesartan—Rash—Fluorouracil—stomach cancer	8.73e-05	0.00061	CcSEcCtD
Irbesartan—Dermatitis—Fluorouracil—stomach cancer	8.72e-05	0.000609	CcSEcCtD
Irbesartan—Pharyngitis—Doxorubicin—stomach cancer	8.71e-05	0.000609	CcSEcCtD
Irbesartan—Paraesthesia—Capecitabine—stomach cancer	8.69e-05	0.000607	CcSEcCtD
Irbesartan—Decreased appetite—Docetaxel—stomach cancer	8.69e-05	0.000607	CcSEcCtD
Irbesartan—Headache—Fluorouracil—stomach cancer	8.68e-05	0.000606	CcSEcCtD
Irbesartan—Urinary tract disorder—Doxorubicin—stomach cancer	8.67e-05	0.000606	CcSEcCtD
Irbesartan—Oedema peripheral—Doxorubicin—stomach cancer	8.65e-05	0.000604	CcSEcCtD
Irbesartan—Dysgeusia—Methotrexate—stomach cancer	8.64e-05	0.000604	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Docetaxel—stomach cancer	8.63e-05	0.000603	CcSEcCtD
Irbesartan—Connective tissue disorder—Doxorubicin—stomach cancer	8.63e-05	0.000603	CcSEcCtD
Irbesartan—Dyspnoea—Capecitabine—stomach cancer	8.63e-05	0.000603	CcSEcCtD
Irbesartan—Fatigue—Docetaxel—stomach cancer	8.62e-05	0.000602	CcSEcCtD
Irbesartan—Angiopathy—Epirubicin—stomach cancer	8.61e-05	0.000601	CcSEcCtD
Irbesartan—Urethral disorder—Doxorubicin—stomach cancer	8.61e-05	0.000601	CcSEcCtD
Irbesartan—Nausea—Irinotecan—stomach cancer	8.59e-05	0.0006	CcSEcCtD
Irbesartan—Immune system disorder—Epirubicin—stomach cancer	8.57e-05	0.000599	CcSEcCtD
Irbesartan—Mediastinal disorder—Epirubicin—stomach cancer	8.55e-05	0.000597	CcSEcCtD
Irbesartan—Constipation—Docetaxel—stomach cancer	8.55e-05	0.000597	CcSEcCtD
Irbesartan—Pain—Docetaxel—stomach cancer	8.55e-05	0.000597	CcSEcCtD
Irbesartan—Dyspepsia—Capecitabine—stomach cancer	8.52e-05	0.000595	CcSEcCtD
Irbesartan—Chills—Epirubicin—stomach cancer	8.51e-05	0.000595	CcSEcCtD
Irbesartan—Arrhythmia—Epirubicin—stomach cancer	8.48e-05	0.000592	CcSEcCtD
Irbesartan—Visual impairment—Doxorubicin—stomach cancer	8.46e-05	0.000591	CcSEcCtD
Irbesartan—Decreased appetite—Capecitabine—stomach cancer	8.41e-05	0.000588	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Capecitabine—stomach cancer	8.35e-05	0.000584	CcSEcCtD
Irbesartan—Fatigue—Capecitabine—stomach cancer	8.34e-05	0.000583	CcSEcCtD
Irbesartan—Vision blurred—Methotrexate—stomach cancer	8.32e-05	0.000581	CcSEcCtD
Irbesartan—Pain—Capecitabine—stomach cancer	8.28e-05	0.000578	CcSEcCtD
Irbesartan—Constipation—Capecitabine—stomach cancer	8.28e-05	0.000578	CcSEcCtD
Irbesartan—Erythema—Epirubicin—stomach cancer	8.26e-05	0.000577	CcSEcCtD
Irbesartan—Malnutrition—Epirubicin—stomach cancer	8.26e-05	0.000577	CcSEcCtD
Irbesartan—Feeling abnormal—Docetaxel—stomach cancer	8.24e-05	0.000575	CcSEcCtD
Irbesartan—Nausea—Fluorouracil—stomach cancer	8.23e-05	0.000575	CcSEcCtD
Irbesartan—Ill-defined disorder—Methotrexate—stomach cancer	8.19e-05	0.000572	CcSEcCtD
Irbesartan—Tinnitus—Doxorubicin—stomach cancer	8.19e-05	0.000572	CcSEcCtD
Irbesartan—Gastrointestinal pain—Docetaxel—stomach cancer	8.17e-05	0.000571	CcSEcCtD
Irbesartan—Anaemia—Methotrexate—stomach cancer	8.16e-05	0.00057	CcSEcCtD
Irbesartan—Flushing—Doxorubicin—stomach cancer	8.15e-05	0.000569	CcSEcCtD
Irbesartan—Cardiac disorder—Doxorubicin—stomach cancer	8.15e-05	0.000569	CcSEcCtD
Irbesartan—Flatulence—Epirubicin—stomach cancer	8.14e-05	0.000569	CcSEcCtD
Irbesartan—Tension—Epirubicin—stomach cancer	8.11e-05	0.000566	CcSEcCtD
Irbesartan—Dysgeusia—Epirubicin—stomach cancer	8.09e-05	0.000565	CcSEcCtD
Irbesartan—Nervousness—Epirubicin—stomach cancer	8.02e-05	0.00056	CcSEcCtD
Irbesartan—Feeling abnormal—Capecitabine—stomach cancer	7.97e-05	0.000557	CcSEcCtD
Irbesartan—Angiopathy—Doxorubicin—stomach cancer	7.97e-05	0.000556	CcSEcCtD
Irbesartan—Malaise—Methotrexate—stomach cancer	7.96e-05	0.000556	CcSEcCtD
Irbesartan—Muscle spasms—Epirubicin—stomach cancer	7.94e-05	0.000555	CcSEcCtD
Irbesartan—Immune system disorder—Doxorubicin—stomach cancer	7.93e-05	0.000554	CcSEcCtD
Irbesartan—Vertigo—Methotrexate—stomach cancer	7.93e-05	0.000554	CcSEcCtD
Irbesartan—Gastrointestinal pain—Capecitabine—stomach cancer	7.91e-05	0.000553	CcSEcCtD
Irbesartan—Mediastinal disorder—Doxorubicin—stomach cancer	7.91e-05	0.000553	CcSEcCtD
Irbesartan—Abdominal pain—Docetaxel—stomach cancer	7.9e-05	0.000552	CcSEcCtD
Irbesartan—Body temperature increased—Docetaxel—stomach cancer	7.9e-05	0.000552	CcSEcCtD
Irbesartan—Leukopenia—Methotrexate—stomach cancer	7.9e-05	0.000552	CcSEcCtD
Irbesartan—Chills—Doxorubicin—stomach cancer	7.88e-05	0.00055	CcSEcCtD
Irbesartan—Arrhythmia—Doxorubicin—stomach cancer	7.84e-05	0.000548	CcSEcCtD
Irbesartan—Vision blurred—Epirubicin—stomach cancer	7.78e-05	0.000544	CcSEcCtD
Irbesartan—Cough—Methotrexate—stomach cancer	7.7e-05	0.000538	CcSEcCtD
Irbesartan—Urticaria—Capecitabine—stomach cancer	7.69e-05	0.000537	CcSEcCtD
Irbesartan—Ill-defined disorder—Epirubicin—stomach cancer	7.66e-05	0.000535	CcSEcCtD
Irbesartan—Abdominal pain—Capecitabine—stomach cancer	7.65e-05	0.000534	CcSEcCtD
Irbesartan—Body temperature increased—Capecitabine—stomach cancer	7.65e-05	0.000534	CcSEcCtD
Irbesartan—Erythema—Doxorubicin—stomach cancer	7.64e-05	0.000534	CcSEcCtD
Irbesartan—Malnutrition—Doxorubicin—stomach cancer	7.64e-05	0.000534	CcSEcCtD
Irbesartan—Anaemia—Epirubicin—stomach cancer	7.63e-05	0.000533	CcSEcCtD
Irbesartan—Agitation—Epirubicin—stomach cancer	7.59e-05	0.00053	CcSEcCtD
Irbesartan—Flatulence—Doxorubicin—stomach cancer	7.53e-05	0.000526	CcSEcCtD
Irbesartan—Chest pain—Methotrexate—stomach cancer	7.51e-05	0.000525	CcSEcCtD
Irbesartan—Myalgia—Methotrexate—stomach cancer	7.51e-05	0.000525	CcSEcCtD
Irbesartan—Arthralgia—Methotrexate—stomach cancer	7.51e-05	0.000525	CcSEcCtD
Irbesartan—Tension—Doxorubicin—stomach cancer	7.5e-05	0.000524	CcSEcCtD
Irbesartan—Dysgeusia—Doxorubicin—stomach cancer	7.48e-05	0.000523	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	7.46e-05	0.000521	CcSEcCtD
Irbesartan—Malaise—Epirubicin—stomach cancer	7.45e-05	0.00052	CcSEcCtD
Irbesartan—Discomfort—Methotrexate—stomach cancer	7.42e-05	0.000519	CcSEcCtD
Irbesartan—Nervousness—Doxorubicin—stomach cancer	7.42e-05	0.000518	CcSEcCtD
Irbesartan—Vertigo—Epirubicin—stomach cancer	7.42e-05	0.000518	CcSEcCtD
Irbesartan—Syncope—Epirubicin—stomach cancer	7.41e-05	0.000517	CcSEcCtD
Irbesartan—Leukopenia—Epirubicin—stomach cancer	7.39e-05	0.000516	CcSEcCtD
Irbesartan—Hypersensitivity—Docetaxel—stomach cancer	7.36e-05	0.000514	CcSEcCtD
Irbesartan—Muscle spasms—Doxorubicin—stomach cancer	7.35e-05	0.000513	CcSEcCtD
Irbesartan—Loss of consciousness—Epirubicin—stomach cancer	7.26e-05	0.000507	CcSEcCtD
Irbesartan—Cough—Epirubicin—stomach cancer	7.21e-05	0.000503	CcSEcCtD
Irbesartan—Anaphylactic shock—Methotrexate—stomach cancer	7.2e-05	0.000503	CcSEcCtD
Irbesartan—Vision blurred—Doxorubicin—stomach cancer	7.2e-05	0.000503	CcSEcCtD
Irbesartan—Asthenia—Docetaxel—stomach cancer	7.17e-05	0.000501	CcSEcCtD
Irbesartan—Infection—Methotrexate—stomach cancer	7.16e-05	0.0005	CcSEcCtD
Irbesartan—Hypertension—Epirubicin—stomach cancer	7.13e-05	0.000498	CcSEcCtD
Irbesartan—Hypersensitivity—Capecitabine—stomach cancer	7.13e-05	0.000498	CcSEcCtD
Irbesartan—Ill-defined disorder—Doxorubicin—stomach cancer	7.09e-05	0.000495	CcSEcCtD
Irbesartan—Pruritus—Docetaxel—stomach cancer	7.07e-05	0.000494	CcSEcCtD
Irbesartan—Nervous system disorder—Methotrexate—stomach cancer	7.06e-05	0.000493	CcSEcCtD
Irbesartan—Anaemia—Doxorubicin—stomach cancer	7.06e-05	0.000493	CcSEcCtD
Irbesartan—Thrombocytopenia—Methotrexate—stomach cancer	7.05e-05	0.000493	CcSEcCtD
Irbesartan—Myalgia—Epirubicin—stomach cancer	7.03e-05	0.000491	CcSEcCtD
Irbesartan—Chest pain—Epirubicin—stomach cancer	7.03e-05	0.000491	CcSEcCtD
Irbesartan—Arthralgia—Epirubicin—stomach cancer	7.03e-05	0.000491	CcSEcCtD
Irbesartan—Agitation—Doxorubicin—stomach cancer	7.02e-05	0.000491	CcSEcCtD
Irbesartan—Anxiety—Epirubicin—stomach cancer	7.01e-05	0.000489	CcSEcCtD
Irbesartan—Skin disorder—Methotrexate—stomach cancer	7e-05	0.000489	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	6.98e-05	0.000488	CcSEcCtD
Irbesartan—Hyperhidrosis—Methotrexate—stomach cancer	6.96e-05	0.000486	CcSEcCtD
Irbesartan—Discomfort—Epirubicin—stomach cancer	6.95e-05	0.000485	CcSEcCtD
Irbesartan—Asthenia—Capecitabine—stomach cancer	6.94e-05	0.000485	CcSEcCtD
Irbesartan—Malaise—Doxorubicin—stomach cancer	6.89e-05	0.000481	CcSEcCtD
Irbesartan—Dry mouth—Epirubicin—stomach cancer	6.88e-05	0.00048	CcSEcCtD
Irbesartan—Vertigo—Doxorubicin—stomach cancer	6.87e-05	0.00048	CcSEcCtD
Irbesartan—Anorexia—Methotrexate—stomach cancer	6.87e-05	0.00048	CcSEcCtD
Irbesartan—Syncope—Doxorubicin—stomach cancer	6.85e-05	0.000479	CcSEcCtD
Irbesartan—Pruritus—Capecitabine—stomach cancer	6.85e-05	0.000478	CcSEcCtD
Irbesartan—Leukopenia—Doxorubicin—stomach cancer	6.84e-05	0.000478	CcSEcCtD
Irbesartan—Diarrhoea—Docetaxel—stomach cancer	6.84e-05	0.000478	CcSEcCtD
Irbesartan—Oedema—Epirubicin—stomach cancer	6.74e-05	0.000471	CcSEcCtD
Irbesartan—Anaphylactic shock—Epirubicin—stomach cancer	6.74e-05	0.000471	CcSEcCtD
Irbesartan—Hypotension—Methotrexate—stomach cancer	6.73e-05	0.00047	CcSEcCtD
Irbesartan—Loss of consciousness—Doxorubicin—stomach cancer	6.72e-05	0.000469	CcSEcCtD
Irbesartan—Infection—Epirubicin—stomach cancer	6.7e-05	0.000468	CcSEcCtD
Irbesartan—Cough—Doxorubicin—stomach cancer	6.67e-05	0.000466	CcSEcCtD
Irbesartan—Shock—Epirubicin—stomach cancer	6.63e-05	0.000463	CcSEcCtD
Irbesartan—Diarrhoea—Capecitabine—stomach cancer	6.62e-05	0.000462	CcSEcCtD
Irbesartan—Nervous system disorder—Epirubicin—stomach cancer	6.61e-05	0.000462	CcSEcCtD
Irbesartan—Dizziness—Docetaxel—stomach cancer	6.61e-05	0.000462	CcSEcCtD
Irbesartan—Thrombocytopenia—Epirubicin—stomach cancer	6.6e-05	0.000461	CcSEcCtD
Irbesartan—Hypertension—Doxorubicin—stomach cancer	6.6e-05	0.000461	CcSEcCtD
Irbesartan—Tachycardia—Epirubicin—stomach cancer	6.58e-05	0.00046	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Methotrexate—stomach cancer	6.56e-05	0.000458	CcSEcCtD
Irbesartan—Skin disorder—Epirubicin—stomach cancer	6.55e-05	0.000457	CcSEcCtD
Irbesartan—Hyperhidrosis—Epirubicin—stomach cancer	6.52e-05	0.000455	CcSEcCtD
Irbesartan—Arthralgia—Doxorubicin—stomach cancer	6.51e-05	0.000454	CcSEcCtD
Irbesartan—Myalgia—Doxorubicin—stomach cancer	6.51e-05	0.000454	CcSEcCtD
Irbesartan—Chest pain—Doxorubicin—stomach cancer	6.51e-05	0.000454	CcSEcCtD
Irbesartan—Anxiety—Doxorubicin—stomach cancer	6.48e-05	0.000453	CcSEcCtD
Irbesartan—Paraesthesia—Methotrexate—stomach cancer	6.47e-05	0.000452	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	6.46e-05	0.000451	CcSEcCtD
Irbesartan—Discomfort—Doxorubicin—stomach cancer	6.43e-05	0.000449	CcSEcCtD
Irbesartan—Anorexia—Epirubicin—stomach cancer	6.43e-05	0.000449	CcSEcCtD
Irbesartan—Dyspnoea—Methotrexate—stomach cancer	6.42e-05	0.000449	CcSEcCtD
Irbesartan—Somnolence—Methotrexate—stomach cancer	6.4e-05	0.000447	CcSEcCtD
Irbesartan—Dizziness—Capecitabine—stomach cancer	6.4e-05	0.000447	CcSEcCtD
Irbesartan—Dry mouth—Doxorubicin—stomach cancer	6.36e-05	0.000444	CcSEcCtD
Irbesartan—Vomiting—Docetaxel—stomach cancer	6.36e-05	0.000444	CcSEcCtD
Irbesartan—Dyspepsia—Methotrexate—stomach cancer	6.34e-05	0.000443	CcSEcCtD
Irbesartan—Rash—Docetaxel—stomach cancer	6.3e-05	0.00044	CcSEcCtD
Irbesartan—Hypotension—Epirubicin—stomach cancer	6.3e-05	0.00044	CcSEcCtD
Irbesartan—Dermatitis—Docetaxel—stomach cancer	6.3e-05	0.00044	CcSEcCtD
Irbesartan—Decreased appetite—Methotrexate—stomach cancer	6.26e-05	0.000437	CcSEcCtD
Irbesartan—Headache—Docetaxel—stomach cancer	6.26e-05	0.000437	CcSEcCtD
Irbesartan—Oedema—Doxorubicin—stomach cancer	6.24e-05	0.000436	CcSEcCtD
Irbesartan—Anaphylactic shock—Doxorubicin—stomach cancer	6.24e-05	0.000436	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Methotrexate—stomach cancer	6.22e-05	0.000434	CcSEcCtD
Irbesartan—Fatigue—Methotrexate—stomach cancer	6.21e-05	0.000434	CcSEcCtD
Irbesartan—Infection—Doxorubicin—stomach cancer	6.2e-05	0.000433	CcSEcCtD
Irbesartan—Pain—Methotrexate—stomach cancer	6.16e-05	0.00043	CcSEcCtD
Irbesartan—Vomiting—Capecitabine—stomach cancer	6.15e-05	0.00043	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Epirubicin—stomach cancer	6.14e-05	0.000429	CcSEcCtD
Irbesartan—Shock—Doxorubicin—stomach cancer	6.14e-05	0.000429	CcSEcCtD
Irbesartan—Nervous system disorder—Doxorubicin—stomach cancer	6.12e-05	0.000427	CcSEcCtD
Irbesartan—Thrombocytopenia—Doxorubicin—stomach cancer	6.11e-05	0.000427	CcSEcCtD
Irbesartan—Rash—Capecitabine—stomach cancer	6.1e-05	0.000426	CcSEcCtD
Irbesartan—Dermatitis—Capecitabine—stomach cancer	6.1e-05	0.000426	CcSEcCtD
Irbesartan—Tachycardia—Doxorubicin—stomach cancer	6.09e-05	0.000425	CcSEcCtD
Irbesartan—Headache—Capecitabine—stomach cancer	6.06e-05	0.000423	CcSEcCtD
Irbesartan—Skin disorder—Doxorubicin—stomach cancer	6.06e-05	0.000423	CcSEcCtD
Irbesartan—Paraesthesia—Epirubicin—stomach cancer	6.05e-05	0.000423	CcSEcCtD
Irbesartan—Hyperhidrosis—Doxorubicin—stomach cancer	6.03e-05	0.000421	CcSEcCtD
Irbesartan—Dyspnoea—Epirubicin—stomach cancer	6.01e-05	0.00042	CcSEcCtD
Irbesartan—Somnolence—Epirubicin—stomach cancer	5.99e-05	0.000419	CcSEcCtD
Irbesartan—Anorexia—Doxorubicin—stomach cancer	5.95e-05	0.000415	CcSEcCtD
Irbesartan—Nausea—Docetaxel—stomach cancer	5.94e-05	0.000415	CcSEcCtD
Irbesartan—Feeling abnormal—Methotrexate—stomach cancer	5.94e-05	0.000415	CcSEcCtD
Irbesartan—Dyspepsia—Epirubicin—stomach cancer	5.93e-05	0.000414	CcSEcCtD
Irbesartan—Gastrointestinal pain—Methotrexate—stomach cancer	5.89e-05	0.000411	CcSEcCtD
Irbesartan—Decreased appetite—Epirubicin—stomach cancer	5.86e-05	0.000409	CcSEcCtD
Irbesartan—Hypotension—Doxorubicin—stomach cancer	5.83e-05	0.000407	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Epirubicin—stomach cancer	5.82e-05	0.000407	CcSEcCtD
Irbesartan—Fatigue—Epirubicin—stomach cancer	5.81e-05	0.000406	CcSEcCtD
Irbesartan—Constipation—Epirubicin—stomach cancer	5.77e-05	0.000403	CcSEcCtD
Irbesartan—Pain—Epirubicin—stomach cancer	5.77e-05	0.000403	CcSEcCtD
Irbesartan—Nausea—Capecitabine—stomach cancer	5.75e-05	0.000401	CcSEcCtD
Irbesartan—Urticaria—Methotrexate—stomach cancer	5.72e-05	0.0004	CcSEcCtD
Irbesartan—Abdominal pain—Methotrexate—stomach cancer	5.69e-05	0.000398	CcSEcCtD
Irbesartan—Body temperature increased—Methotrexate—stomach cancer	5.69e-05	0.000398	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Doxorubicin—stomach cancer	5.68e-05	0.000397	CcSEcCtD
Irbesartan—Paraesthesia—Doxorubicin—stomach cancer	5.6e-05	0.000391	CcSEcCtD
Irbesartan—Dyspnoea—Doxorubicin—stomach cancer	5.56e-05	0.000388	CcSEcCtD
Irbesartan—Feeling abnormal—Epirubicin—stomach cancer	5.56e-05	0.000388	CcSEcCtD
Irbesartan—Somnolence—Doxorubicin—stomach cancer	5.55e-05	0.000387	CcSEcCtD
Irbesartan—Gastrointestinal pain—Epirubicin—stomach cancer	5.51e-05	0.000385	CcSEcCtD
Irbesartan—Dyspepsia—Doxorubicin—stomach cancer	5.49e-05	0.000384	CcSEcCtD
Irbesartan—Decreased appetite—Doxorubicin—stomach cancer	5.42e-05	0.000379	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Doxorubicin—stomach cancer	5.39e-05	0.000376	CcSEcCtD
Irbesartan—Fatigue—Doxorubicin—stomach cancer	5.38e-05	0.000376	CcSEcCtD
Irbesartan—Urticaria—Epirubicin—stomach cancer	5.36e-05	0.000374	CcSEcCtD
Irbesartan—Constipation—Doxorubicin—stomach cancer	5.33e-05	0.000373	CcSEcCtD
Irbesartan—Pain—Doxorubicin—stomach cancer	5.33e-05	0.000373	CcSEcCtD
Irbesartan—Abdominal pain—Epirubicin—stomach cancer	5.33e-05	0.000372	CcSEcCtD
Irbesartan—Body temperature increased—Epirubicin—stomach cancer	5.33e-05	0.000372	CcSEcCtD
Irbesartan—Hypersensitivity—Methotrexate—stomach cancer	5.31e-05	0.000371	CcSEcCtD
Irbesartan—Asthenia—Methotrexate—stomach cancer	5.17e-05	0.000361	CcSEcCtD
Irbesartan—Feeling abnormal—Doxorubicin—stomach cancer	5.14e-05	0.000359	CcSEcCtD
Irbesartan—Gastrointestinal pain—Doxorubicin—stomach cancer	5.1e-05	0.000356	CcSEcCtD
Irbesartan—Pruritus—Methotrexate—stomach cancer	5.1e-05	0.000356	CcSEcCtD
Irbesartan—Hypersensitivity—Epirubicin—stomach cancer	4.97e-05	0.000347	CcSEcCtD
Irbesartan—Urticaria—Doxorubicin—stomach cancer	4.96e-05	0.000346	CcSEcCtD
Irbesartan—Abdominal pain—Doxorubicin—stomach cancer	4.93e-05	0.000344	CcSEcCtD
Irbesartan—Body temperature increased—Doxorubicin—stomach cancer	4.93e-05	0.000344	CcSEcCtD
Irbesartan—Diarrhoea—Methotrexate—stomach cancer	4.93e-05	0.000344	CcSEcCtD
Irbesartan—Asthenia—Epirubicin—stomach cancer	4.84e-05	0.000338	CcSEcCtD
Irbesartan—Pruritus—Epirubicin—stomach cancer	4.77e-05	0.000333	CcSEcCtD
Irbesartan—Dizziness—Methotrexate—stomach cancer	4.76e-05	0.000333	CcSEcCtD
Irbesartan—Diarrhoea—Epirubicin—stomach cancer	4.61e-05	0.000322	CcSEcCtD
Irbesartan—Hypersensitivity—Doxorubicin—stomach cancer	4.6e-05	0.000321	CcSEcCtD
Irbesartan—Vomiting—Methotrexate—stomach cancer	4.58e-05	0.00032	CcSEcCtD
Irbesartan—Rash—Methotrexate—stomach cancer	4.54e-05	0.000317	CcSEcCtD
Irbesartan—Dermatitis—Methotrexate—stomach cancer	4.54e-05	0.000317	CcSEcCtD
Irbesartan—Headache—Methotrexate—stomach cancer	4.51e-05	0.000315	CcSEcCtD
Irbesartan—Asthenia—Doxorubicin—stomach cancer	4.48e-05	0.000313	CcSEcCtD
Irbesartan—Dizziness—Epirubicin—stomach cancer	4.46e-05	0.000311	CcSEcCtD
Irbesartan—Pruritus—Doxorubicin—stomach cancer	4.41e-05	0.000308	CcSEcCtD
Irbesartan—Vomiting—Epirubicin—stomach cancer	4.29e-05	0.000299	CcSEcCtD
Irbesartan—Nausea—Methotrexate—stomach cancer	4.28e-05	0.000299	CcSEcCtD
Irbesartan—Diarrhoea—Doxorubicin—stomach cancer	4.27e-05	0.000298	CcSEcCtD
Irbesartan—Rash—Epirubicin—stomach cancer	4.25e-05	0.000297	CcSEcCtD
Irbesartan—Dermatitis—Epirubicin—stomach cancer	4.25e-05	0.000297	CcSEcCtD
Irbesartan—Headache—Epirubicin—stomach cancer	4.22e-05	0.000295	CcSEcCtD
Irbesartan—Dizziness—Doxorubicin—stomach cancer	4.12e-05	0.000288	CcSEcCtD
Irbesartan—Nausea—Epirubicin—stomach cancer	4e-05	0.00028	CcSEcCtD
Irbesartan—Vomiting—Doxorubicin—stomach cancer	3.97e-05	0.000277	CcSEcCtD
Irbesartan—Rash—Doxorubicin—stomach cancer	3.93e-05	0.000275	CcSEcCtD
Irbesartan—Dermatitis—Doxorubicin—stomach cancer	3.93e-05	0.000274	CcSEcCtD
Irbesartan—Headache—Doxorubicin—stomach cancer	3.91e-05	0.000273	CcSEcCtD
Irbesartan—Nausea—Doxorubicin—stomach cancer	3.71e-05	0.000259	CcSEcCtD
Irbesartan—CYP3A4—Metabolism—CKB—stomach cancer	7.68e-06	5.45e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CA1—stomach cancer	7.68e-06	5.45e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—RORA—stomach cancer	7.68e-06	5.45e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GSTP1—stomach cancer	7.68e-06	5.45e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—MAPK1—stomach cancer	7.65e-06	5.43e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—EGFR—stomach cancer	7.65e-06	5.43e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—HMOX1—stomach cancer	7.57e-06	5.37e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PDHA1—stomach cancer	7.55e-06	5.36e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ECHS1—stomach cancer	7.55e-06	5.36e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—ERBB2—stomach cancer	7.53e-06	5.35e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6—stomach cancer	7.49e-06	5.32e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCND1—stomach cancer	7.34e-06	5.21e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.33e-06	5.2e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—JUN—stomach cancer	7.33e-06	5.2e-05	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—PIK3CA—stomach cancer	7.31e-06	5.19e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SERPINE1—stomach cancer	7.3e-06	5.18e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALDOB—stomach cancer	7.26e-06	5.15e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—KRAS—stomach cancer	7.23e-06	5.13e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLIN2—stomach cancer	7.22e-06	5.13e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—HRAS—stomach cancer	7.2e-06	5.11e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALDOB—stomach cancer	7.2e-06	5.11e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTT1—stomach cancer	7.15e-06	5.08e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—TYMS—stomach cancer	7.14e-06	5.07e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP9—stomach cancer	7.13e-06	5.06e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IRS2—stomach cancer	7.1e-06	5.04e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CDKN1A—stomach cancer	7.1e-06	5.04e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TYMP—stomach cancer	7.09e-06	5.04e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—FADS1—stomach cancer	7.09e-06	5.04e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP2A6—stomach cancer	7.07e-06	5.02e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTGS2—stomach cancer	7.06e-06	5.01e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GSTM1—stomach cancer	7.05e-06	5.01e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—RHOA—stomach cancer	7.04e-06	5e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CA2—stomach cancer	7.03e-06	4.99e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—CDKN1B—stomach cancer	6.98e-06	4.95e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NOS3—stomach cancer	6.97e-06	4.95e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MAPK8—stomach cancer	6.93e-06	4.92e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6—stomach cancer	6.89e-06	4.89e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CAV1—stomach cancer	6.89e-06	4.89e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—AKR1C3—stomach cancer	6.88e-06	4.88e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOA1—stomach cancer	6.87e-06	4.88e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1B—stomach cancer	6.85e-06	4.87e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NT5E—stomach cancer	6.85e-06	4.86e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PGAM1—stomach cancer	6.85e-06	4.86e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.79e-06	4.82e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.77e-06	4.81e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALOX5—stomach cancer	6.75e-06	4.79e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ENO1—stomach cancer	6.7e-06	4.76e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALOX5—stomach cancer	6.69e-06	4.75e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SREBF2—stomach cancer	6.64e-06	4.72e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—DPYD—stomach cancer	6.64e-06	4.71e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—PIK3CA—stomach cancer	6.64e-06	4.71e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ERCC2—stomach cancer	6.63e-06	4.71e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.59e-06	4.68e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—DPYD—stomach cancer	6.58e-06	4.67e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—RORA—stomach cancer	6.56e-06	4.66e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PRKCB—stomach cancer	6.56e-06	4.65e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLCE1—stomach cancer	6.53e-06	4.64e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALDH7A1—stomach cancer	6.53e-06	4.64e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6ST—stomach cancer	6.53e-06	4.64e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ERBB2—stomach cancer	6.52e-06	4.63e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—CDKN1A—stomach cancer	6.44e-06	4.57e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—VEGFA—stomach cancer	6.4e-06	4.54e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—STAT3—stomach cancer	6.34e-06	4.5e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—MAPK8—stomach cancer	6.29e-06	4.46e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APC—stomach cancer	6.27e-06	4.45e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—UMPS—stomach cancer	6.26e-06	4.45e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—MTHFR—stomach cancer	6.23e-06	4.43e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL8—stomach cancer	6.18e-06	4.39e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALDOB—stomach cancer	6.15e-06	4.37e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HRAS—stomach cancer	6.14e-06	4.36e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MAPK3—stomach cancer	6.05e-06	4.3e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CDKN1B—stomach cancer	6.04e-06	4.29e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.97e-06	4.24e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CD44—stomach cancer	5.94e-06	4.22e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MYC—stomach cancer	5.89e-06	4.18e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6—stomach cancer	5.88e-06	4.17e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTT1—stomach cancer	5.87e-06	4.17e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6R—stomach cancer	5.83e-06	4.14e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PDHA1—stomach cancer	5.82e-06	4.13e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ECHS1—stomach cancer	5.82e-06	4.13e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTT1—stomach cancer	5.82e-06	4.13e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP2A6—stomach cancer	5.8e-06	4.12e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	5.8e-06	4.12e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	5.79e-06	4.11e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.77e-06	4.09e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCND1—stomach cancer	5.76e-06	4.09e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MAPK1—stomach cancer	5.76e-06	4.09e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—EGFR—stomach cancer	5.76e-06	4.09e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP2A6—stomach cancer	5.75e-06	4.09e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CAV1—stomach cancer	5.75e-06	4.08e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—JUN—stomach cancer	5.75e-06	4.08e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—STAT3—stomach cancer	5.75e-06	4.08e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOA1—stomach cancer	5.74e-06	4.07e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALOX5—stomach cancer	5.72e-06	4.06e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AKR1C3—stomach cancer	5.65e-06	4.01e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—DPYD—stomach cancer	5.63e-06	3.99e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AKR1C3—stomach cancer	5.6e-06	3.97e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP9—stomach cancer	5.59e-06	3.97e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CDKN1A—stomach cancer	5.57e-06	3.96e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ENO1—stomach cancer	5.5e-06	3.91e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.49e-06	3.9e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—MAPK3—stomach cancer	5.49e-06	3.9e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TYMP—stomach cancer	5.48e-06	3.89e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—FADS1—stomach cancer	5.48e-06	3.89e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ENO1—stomach cancer	5.46e-06	3.87e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SERPINE1—stomach cancer	5.45e-06	3.87e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—KRAS—stomach cancer	5.44e-06	3.86e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MAPK8—stomach cancer	5.44e-06	3.86e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.37e-06	3.81e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RHOA—stomach cancer	5.26e-06	3.74e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—MAPK1—stomach cancer	5.22e-06	3.71e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—EGFR—stomach cancer	5.22e-06	3.71e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NOS3—stomach cancer	5.21e-06	3.7e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SREBF2—stomach cancer	5.13e-06	3.64e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.1e-06	3.62e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—RORA—stomach cancer	5.07e-06	3.6e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PPARG—stomach cancer	5.05e-06	3.59e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPP2R1A—stomach cancer	5.05e-06	3.59e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—VEGFA—stomach cancer	5.02e-06	3.57e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PIK3CA—stomach cancer	5e-06	3.55e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTT1—stomach cancer	4.97e-06	3.53e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—STAT3—stomach cancer	4.97e-06	3.53e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTP1—stomach cancer	4.96e-06	3.52e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—KRAS—stomach cancer	4.93e-06	3.5e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP2A6—stomach cancer	4.92e-06	3.49e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—HMOX1—stomach cancer	4.89e-06	3.47e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CD44—stomach cancer	4.88e-06	3.46e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ERBB2—stomach cancer	4.87e-06	3.46e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CD44—stomach cancer	4.84e-06	3.43e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TP53—stomach cancer	4.84e-06	3.43e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AKR1C3—stomach cancer	4.78e-06	3.4e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MAPK3—stomach cancer	4.75e-06	3.37e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALDOB—stomach cancer	4.75e-06	3.37e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.69e-06	3.33e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ENO1—stomach cancer	4.66e-06	3.31e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HRAS—stomach cancer	4.62e-06	3.28e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MYC—stomach cancer	4.62e-06	3.28e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL8—stomach cancer	4.62e-06	3.28e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—TYMS—stomach cancer	4.61e-06	3.27e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.58e-06	3.25e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTM1—stomach cancer	4.56e-06	3.23e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ALB—stomach cancer	4.55e-06	3.23e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—PIK3CA—stomach cancer	4.53e-06	3.22e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MAPK1—stomach cancer	4.52e-06	3.21e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—EGFR—stomach cancer	4.52e-06	3.21e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CDKN1B—stomach cancer	4.51e-06	3.2e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—stomach cancer	4.43e-06	3.14e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALOX5—stomach cancer	4.41e-06	3.13e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NOS3—stomach cancer	4.35e-06	3.09e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PIK3CA—stomach cancer	4.34e-06	3.08e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DPYD—stomach cancer	4.34e-06	3.08e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCND1—stomach cancer	4.3e-06	3.06e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ERCC2—stomach cancer	4.28e-06	3.04e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—KRAS—stomach cancer	4.27e-06	3.03e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—HRAS—stomach cancer	4.19e-06	2.98e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP9—stomach cancer	4.18e-06	2.97e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CDKN1A—stomach cancer	4.16e-06	2.96e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPP2R1A—stomach cancer	4.15e-06	2.95e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CD44—stomach cancer	4.13e-06	2.93e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPP2R1A—stomach cancer	4.11e-06	2.92e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTP1—stomach cancer	4.07e-06	2.89e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MAPK8—stomach cancer	4.06e-06	2.88e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTP1—stomach cancer	4.04e-06	2.86e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MTHFR—stomach cancer	4.03e-06	2.86e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—HMOX1—stomach cancer	4.01e-06	2.85e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—stomach cancer	4.01e-06	2.85e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.01e-06	2.85e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—HMOX1—stomach cancer	3.98e-06	2.83e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGS2—stomach cancer	3.98e-06	2.82e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PIK3CA—stomach cancer	3.92e-06	2.78e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTT1—stomach cancer	3.84e-06	2.73e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP2A6—stomach cancer	3.8e-06	2.69e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TP53—stomach cancer	3.79e-06	2.69e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TYMS—stomach cancer	3.78e-06	2.69e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—VEGFA—stomach cancer	3.75e-06	2.66e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TYMS—stomach cancer	3.75e-06	2.66e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTM1—stomach cancer	3.74e-06	2.66e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—STAT3—stomach cancer	3.72e-06	2.64e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CAV1—stomach cancer	3.71e-06	2.64e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTM1—stomach cancer	3.71e-06	2.63e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOA1—stomach cancer	3.71e-06	2.63e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AKR1C3—stomach cancer	3.69e-06	2.62e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HRAS—stomach cancer	3.63e-06	2.58e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ENO1—stomach cancer	3.6e-06	2.55e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MAPK3—stomach cancer	3.55e-06	2.52e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.55e-06	2.52e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ERCC2—stomach cancer	3.52e-06	2.5e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPP2R1A—stomach cancer	3.52e-06	2.5e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ERCC2—stomach cancer	3.49e-06	2.47e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—stomach cancer	3.47e-06	2.47e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MYC—stomach cancer	3.45e-06	2.45e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTP1—stomach cancer	3.45e-06	2.45e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—HMOX1—stomach cancer	3.4e-06	2.41e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MAPK1—stomach cancer	3.38e-06	2.4e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—EGFR—stomach cancer	3.38e-06	2.4e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MTHFR—stomach cancer	3.31e-06	2.35e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MTHFR—stomach cancer	3.28e-06	2.33e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPARG—stomach cancer	3.27e-06	2.32e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TYMS—stomach cancer	3.21e-06	2.28e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CD44—stomach cancer	3.19e-06	2.27e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—KRAS—stomach cancer	3.19e-06	2.26e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTM1—stomach cancer	3.17e-06	2.25e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CAV1—stomach cancer	3.05e-06	2.16e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOA1—stomach cancer	3.04e-06	2.16e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CAV1—stomach cancer	3.02e-06	2.15e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOA1—stomach cancer	3.02e-06	2.14e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ERCC2—stomach cancer	2.98e-06	2.11e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALB—stomach cancer	2.94e-06	2.08e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PIK3CA—stomach cancer	2.93e-06	2.08e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.89e-06	2.05e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TP53—stomach cancer	2.83e-06	2.01e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NOS3—stomach cancer	2.81e-06	1.99e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MTHFR—stomach cancer	2.8e-06	1.99e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.71e-06	1.93e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HRAS—stomach cancer	2.71e-06	1.92e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPARG—stomach cancer	2.68e-06	1.9e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTP1—stomach cancer	2.66e-06	1.89e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPARG—stomach cancer	2.66e-06	1.89e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HMOX1—stomach cancer	2.62e-06	1.86e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—stomach cancer	2.59e-06	1.84e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CAV1—stomach cancer	2.58e-06	1.83e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOA1—stomach cancer	2.58e-06	1.83e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGS2—stomach cancer	2.57e-06	1.82e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TYMS—stomach cancer	2.47e-06	1.76e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.47e-06	1.75e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PIK3CA—stomach cancer	2.45e-06	1.74e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTM1—stomach cancer	2.45e-06	1.74e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALB—stomach cancer	2.41e-06	1.71e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALB—stomach cancer	2.39e-06	1.7e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NOS3—stomach cancer	2.31e-06	1.64e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ERCC2—stomach cancer	2.3e-06	1.63e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NOS3—stomach cancer	2.29e-06	1.62e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPARG—stomach cancer	2.27e-06	1.61e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MTHFR—stomach cancer	2.16e-06	1.53e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGS2—stomach cancer	2.11e-06	1.5e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGS2—stomach cancer	2.09e-06	1.48e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALB—stomach cancer	2.04e-06	1.45e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CAV1—stomach cancer	1.99e-06	1.42e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOA1—stomach cancer	1.99e-06	1.41e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NOS3—stomach cancer	1.95e-06	1.39e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGS2—stomach cancer	1.79e-06	1.27e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPARG—stomach cancer	1.75e-06	1.24e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PIK3CA—stomach cancer	1.58e-06	1.12e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALB—stomach cancer	1.58e-06	1.12e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NOS3—stomach cancer	1.51e-06	1.07e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGS2—stomach cancer	1.38e-06	9.79e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.3e-06	9.21e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.29e-06	9.13e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.1e-06	7.8e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PIK3CA—stomach cancer	8.48e-07	6.02e-06	CbGpPWpGaD
